Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;3(12):e12645.
doi: 10.14814/phy2.12645.

Impact of UGT2B17 gene deletion on the steroid profile of an athlete

Pilar Martín-Escudero  1 , Jesús Muñoz-Guerra  2 , Nayade Del Prado  3 , Mercedes Galindo Canales  4 , Manuel Fuentes Ferrer  3 , Soledad Vargas  2 , Ana B Soldevilla  2 , Ester Serrano-Garde  2 , Francisco Miguel-Tobal  4 , Marisa Maestro de Las Casas  5 , Cristina Fernandez-Pérez  3
Affiliations

Impact of UGT2B17 gene deletion on the steroid profile of an athlete

Pilar Martín-Escudero et al. Physiol Rep. 2015 Dec.

Abstract

The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports-medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.

Keywords: Exercise; UGT2B17 genotype; doping; steroid profile.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Data collection process.
Figure 2
Figure 2
Testosterone/epitestosterone ratio according to demographic, sports, and genetic variables.
See this image and copyright information in PMC

References

    1. Baron, D. A. , Martin D. M., and Magd S. A.. 2007. Doping in sport and its spread to populations at risk: an international review. World Psychiatry (Ed Esp) 5:118–123. - PMC - PubMed
    1. Donike, M. , Rauth S., and Wolansky A.. 1993. Reference ranges of urinary endogenous steroids determined by gas chromatography/mass spectrometry Pp. 69–86 in Proceedings of the 10th Cologne Workshop on Dope Analysis. Sport und Buch Strauß, Cologne.
    1. Ekström, L. , Cevenini L., Michelini E., Schulze J., Thörngren J. O., Belanger A., et al. 2013. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes. Eur. J. Clin. Invest. 43:248–255. - PubMed
    1. Fabregat, A. , Pozo O. J., Marcos J., Segura J., and Ventura R.. 2010. Quantification of testosterone and metabolites released after alkaline treatment in human urine. Drug Test Anal. 2:630–636. - PubMed
    1. Gallagher, C. J. , Kadlubar F. F., Muscat J. E., Ambrosone C. B., Lang N. P., and Lazarus P.. 2007a. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case‐control study in Caucasians. Cancer Detect. Prev. 31:310–315. - PMC - PubMed